NRT Smoking Cessation Aids in the US

NRT Smoking Cessation Aids in the US

  • September 2016
  • 30 pages
  • Euromonitor International
Report ID: 149238
Although posting current value growth of 6% in 2016, NRT smoking cessation aids is suffering from a shrinking customer base. Smoking prevalence in the US steadily declined over the review period to 16% of the adult population, or roughly 37 million people. Tobacco products are highly regulated in the US and many state and federal government agencies sponsor anti-smoking campaigns. A 2013 study sponsored by the CDC estimated that cigarette smoking is responsible for as much as US$170 billion of a...

Euromonitor International’s NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=UnitedStates Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000